LSP Invests in Vivasure Medical

Palo Alto – September 19, 2016 – Cooley performed the patent due diligence on behalf of LSP in connection with its Series C investment in Vivasure Medical.

LSP led the round with $18.3 million from its LSP Health Economics Fund. The funding will support European commercialization of Vivasure’s PerQseal technology to meet the growing demand for absorbable, percutaneous vessel closure products, as well as execution of an FDA regulatory study.

LSP is an independent European investment firm, providing financing for private and public life sciences companies. Vivasure is a medical device company based at Europe’s leading medtech cluster in Galway, Ireland.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.